Our topic is "Transantral Decompression for Malignant Exophthalmos." As the title indicates, this is another example in the ever-widening field of otolaryngology. If the welfare of the patient is served, diversification is permissible. It is our firm belief that the otolaryngologist can offer substantial aid to the patient suffering from malignant exophthalmos.
Despite tremendous advances in diagnostic methods and therapeutic procedures available for the management of Graves' disease, exophthalmos remains its most baffling and least understood component. Differentiation into thyrotoxic and thyrotropic (malignant) exophthalmos serves a useful purpose from the clinical standpoint.
Thyrotoxic exophthalmos is a relatively mild involvement characterized by a slight "compressible" type of ocular protrusion, lid retraction, and possibly some thinning of the extraocular muscles. Except for the undesirable cosmetic effect the condition is harmless and the prognosis favorable.
Our discussion deals with thyrotropic exophthalmos (also described as malignant, progressive, or endocrine exophthalmos, hyperophthalmos of Graves' disease,
WALKER JS, PORTER GL. Transantral Decompression for Malignant Exophthalmos. AMA Arch Otolaryngol. 1958;68(2):152–155. doi:10.1001/archotol.1958.00730020158004
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: